WADA will not appeal UCI verdict on Chris Froome salbutamol case

Chris Froome celebrates on the stage 20 podium at tge Giro

The World Anti-Doping Agency announced on Monday that it will not appeal the UCI's decision to clear Chris Froome of any anti-doping rule violations from the 2017 Vuelta a Espana. The agency's press release confirmed that Froome did not undergo the controlled pharmacokinetic study (CPKS) allowed under WADA rules to prove that the level of salbutamol in his Vuelta urine sample that exceeded the allowed threshold was a normal consequence of his physiology. "In Mr. Froome's case, WADA accepts that a CPKS would not have been practicable as it would not have been possible to adequately recreate the unique circumstances that preceded the 7 September doping control," the press release stated. WADA arrived at the decision "based on a number of factors that are specific to the case of Mr. Froome – including, in particular, a significant increase in dose, over a short period prior to the doping control, in ...

Read on Cycling News


More Like This

Card image cap

WADA decides against Froome anti-doping appeal

View
Card image cap

UCI says no reasoned decision will be released for Froome case, elaborates on related topics

View
Card image cap

Opinion: Why WADA and the UCI’s handling of the Froome case is damaging to sport

View
Card image cap

UK Anti-Doping data a blow to Chris Froome's salbutamol defence

View
Card image cap

UCI drops investigation into Froome, says it accepts no rules were broken in Salbutamol case

View
Card image cap

WADA explains why it cleared Froome, Prudhomme confirms rider can compete in Tour

View
Card image cap

Analysis: WADA appears to contradict UCI over Froome case decision

View
Card image cap

Petacchi feels vindicated by resolution of Chris Froome case

View
Card image cap

UCI responds to criticism surrounding Chris Froome judgement

View
Card image cap

Research paper raises questions about Salbutamol tests, may aid Froome’s defence

View